{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-110316","form_type":"8-K","ticker":"KALA","cik":"0001479419","company_name":"KALA BIO, Inc.","filed_at":"2025-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.495348+00:00","generated_at":"2026-05-16T21:04:18.436669+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"confidence":"high","headline":"KALA BIO receives Nasdaq deficiency notice for MVLS below $35M; 180 days to comply","bullets":["Nasdaq notified KALA BIO on Nov 10, 2025 that MVLS was below $35M for 30 consecutive business days, violating Listing Rule 5550(b)(2).","Company also fails alternative standards: stockholders' equity <$2.5M and no net income from continuing operations in recent fiscal years.","Has until May 11, 2026 to regain compliance; if MVLS is at least $35M for 10 consecutive days, compliance is restored.","If not compliant by the deadline, stock subject to delisting; company may appeal to a Nasdaq Listing Qualifications Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-110316","json":"https://secwatch.observer/filing/0001104659-25-110316.json","markdown":"https://secwatch.observer/filing/0001104659-25-110316.md","text":"https://secwatch.observer/filing/0001104659-25-110316.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925110316/0001104659-25-110316-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1479419/000110465925110316/kala-20251110x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T21:04:18.436669+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}